Cystatin C as a predictor of renal recovery and in hospital mortality in patients with acute kidney injury and liver cirrhosis
- PMID: 40707908
- PMCID: PMC12288214
- DOI: 10.1186/s12882-025-04341-7
Cystatin C as a predictor of renal recovery and in hospital mortality in patients with acute kidney injury and liver cirrhosis
Abstract
Background: Acute kidney injury (AKI) is a common and serious complication in patients with liver cirrhosis, with pre-renal AKI and acute tubular necrosis being the most frequent underlying causes. Cystatin C is a non-glycosylated 13 kDa protein that is consistently produced by all nucleated cells and has been suggested as a potential predictor of mortality in this patient population. The role of cystatin C in predicting renal recovery in these patients is not known and this was the aim of our study.
Methods: This was a retrospective single center study that included hospitalized patients with liver cirrhosis who developed or were admitted with AKI and had serum cystatin C in their records from May 2017 to May 2023. The sociodemographic and laboratory data were retrieved from the data system. The in-hospital mortality, length of hospital stay, and renal recovery were recorded. Renal recovery was defined as a reduction in serum creatinine without needing dialysis on discharge.
Results: This study included 209 patients with AKI and liver cirrhosis. Sixty-five patients (31%) died during hospital admission. The renal recovery was shown in 136 patients (65%). White blood cells, serum albumin, and peak serum cystatin C were the significant predictors for in-hospital mortality (p = 0.021, 0.013, and 0.001, respectively). Hypertension, serum albumin, baseline creatinine and baseline cystatin C were significant predictors of renal recovery in the studied patients (p = 0.017, 0.006, 0.030, and < 0.001, respectively). The cut-off value of baseline serum cystatin C for prediction of renal recovery was 2.62 with moderate sensitivity and specificity.
Conclusion: In the current study, baseline serum cystatin C is a predictor of renal recovery in patients with AKI and liver cirrhosis. However, peak serum cystatin C is a predictor of mortality in these patients.
Keywords: AKI; Cystatin C; Liver cirrhosis; Mortality; Renal recovery.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was adhered to the Declaration of Helsinki and was approved by the University of Kentucky institutional review board (IRB number 86422, dated 7/6/2024. Informed consent was waived due to the retrospective nature of the study and the minimal risk to participants. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Pseudo acute kidney injury in patients receiving CDK4/6 inhibitors.Br J Cancer. 2025 Apr;132(6):525-532. doi: 10.1038/s41416-025-02951-4. Epub 2025 Feb 10. Br J Cancer. 2025. PMID: 39930149
-
Reduction Rate of Uric Acid in Blood during Continuous Renal Replacement Therapy for Acute Kidney Injury: A Multicenter Retrospective Observational Study.Blood Purif. 2025;54(2):83-92. doi: 10.1159/000542329. Epub 2024 Oct 29. Blood Purif. 2025. PMID: 39471783 Free PMC article.
-
RECOVID: Retrospective Observational Study of Renal Outcomes and Long-Term Mortality in Patients With COVID-19-Associated AKI, A Comparison Between Vaccinated and Unvaccinated Patients.Kidney Med. 2025 Jun 18;7(7):101020. doi: 10.1016/j.xkme.2025.101020. eCollection 2025 Jul. Kidney Med. 2025. PMID: 40607207 Free PMC article.
-
HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.Cochrane Database Syst Rev. 2015 Mar 11;2015(3):CD010480. doi: 10.1002/14651858.CD010480.pub2. Cochrane Database Syst Rev. 2015. PMID: 25758322 Free PMC article.
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
References
-
- Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology. 2008;48:2064–77. - PubMed
-
- Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361:1279–90. - PubMed
-
- Barton AL, Williams SB, Dickinson SJ, Parry RG, Pollard A. Acute kidney injury in primary care: a review of patient follow-up, mortality, and hospital admissions following the introduction of an AKI alert system. Nephron. 2020;144:498–505. - PubMed
-
- Bucaloiu ID, Kirchner HL, Norfolk ER, Hartle IIJE, Perkins RM. Increased risk of death and de Novo chronic kidney disease following reversible acute kidney injury. Kidney Int. 2012;81:477–85. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical